Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
Latest Information Update: 04 Oct 2022
At a glance
- Drugs Itacitinib (Primary)
- Indications Aplastic anaemia
- Focus Expanded access; Therapeutic Use
- Sponsors Incyte Corporation
- 25 Jul 2022 Status changed from recruiting to completed.
- 10 Apr 2019 New trial record